Please set your featured image
OGT signs license with Wellcome Trust Sanger Institute
Oxford Gene Technology (OGT), the molecular genetics company, has announced that it has signed a license agreement with the Wellcome Trust Sanger Institute for access to data from the Deciphering Developmental Disorders (DDD) study.
The DDD study has successfully identified new areas of the genome as responsible for developmental disorders. OGT plans to use this ground-breaking information, combined with the latest updates from the International Collaboration for Clinical Genomics (ICCG) consortium, to develop its CytoSure Constitutional v3 range, an advance on OGT’s successful CytoSure ISCA arrays.
The new line of genome-wide arrays incorporating the study results is expected next month.
OGT was founded in 1995 by gene-sequencing pioneer Professor Sir Ed Southern, and is based at Begbroke Science Park. For more information, visit the OGT website.